ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002

GYN Group: Open Surgery Would Cost More Lives Than Morcellation

July 25, 2014

NCAB Supports ACS Effort To Work With Centers

March 1, 1991

Search for New NCI director focuses On California; Possibilities Include Korn, Beahrs, Gale, Others

September 23, 1988

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

January 4, 1991